TG Therapeutics, Inc. (TGTX) Stock Forecast & Price Prediction 2024, 2025, 2030, 2040, and 2050
Stay updated on TG Therapeutics, Inc. (TGTX) stock with short-term forecast for year 2024 and long-term price prediction for 2025 - 2050. Access historical performance, see analyst ratings, and follow the latest TG Therapeutics, Inc. news and developments.
1 Month Prediction
$35.07 [0.00%]
3 Month Prediction
$33.70 [-3.92%]
6 Month Prediction
$24.20 [-30.98%]
1 Year Prediction
$29.69 [-15.33%]
3 Year Prediction
$29.71 [-15.27%]
5 Year Prediction
$29.99 [-14.50%]
About TG Therapeutics, Inc.
TG Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing innovative treatments for B-cell-mediated diseases. The company's lead product, BRIUMVI® (ublituximab-xiiy), is an anti-CD20 monoclonal antibody approved for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS).
In November 2024, TG Therapeutics was recognized as the fastest-growing company in North America, ranking number one on the Deloitte Technology Fast 500™.
The company's development pipeline includes investigational medicines such as TG-1701, an orally available Bruton's tyrosine kinase (BTK) inhibitor, and TG-1801, a bispecific CD47 and CD19 antibody.
TG Therapeutics, Inc. (TGTX) Historical Performance
IPO Date
TG Therapeutics, Inc. (NASDAQ:TGTX) went public on 14 December, 1995.
Change
Since inception, TGTX has decreased by 72.29%. In the last 5 years, TGTX has risen from $11.10 to $35.07, a massive 215.95% increase since 2019.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $52.02 and a low of $4.25.
52 Week Range
$12.3
$36.5
The current price $35.07 is near the 52-week high, which means that the stock is overbought.
TGTX Stock Price History
Based on TGTX stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2018, the TGTX stock has risen from $4.1 - $11.1 to $13.66 - $35.07, which is up 394.88%. Currently, the stock follows upward trend.
Here, we have calculated stock range of TGTX, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2019 | $4.1 - $11.1 | $7.27 | 77.32 | 1 Year Change |
| 2020 | $9.84 - $52.02 | $22.02 | 437.07 | 2 Year Change |
| 2021 | $15.2 - $48.27 | $34.95 | 752.44 | 3 Year Change |
| 2022 | $4.25 - $11.83 | $7.67 | 87.07 | 4 Year Change |
| 2023 | $7.73 - $26.63 | $16.64 | 305.85 | 5 Year Change |
| 2024 | $13.66 - $35.07 | $20.29 | 394.88 | 6 Year Change |
TGTX Price Performance
6-Month Performance
TGTX stock jumped by 97.13% in the last six months.
1-Year Performance
The stock has trended upwards by 105.33% in the past year.
3-Year Performance
In the last 3 years, the stock has soared by 84.58%.
5-Year Performance
In the last 5 years, the stock has gone up by 215.95%.
According to TG Therapeutics, Inc.'s historical data, below graph gives us the exact picture of how the TGTX stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 3 years and a decline in 2 years.
2019
170.73% ↑
2020
368.65% ↑
2021
63.48% ↓
2022
37.74% ↓
2023
44.38% ↑
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
TG Therapeutics, Inc. (TGTX) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $83.88 M (Q3)
Revenue for Q3 ending 30th September, 2024 increased 14.17% compared to Q2 ending 30th June, 2024.
Annual Revenue: $264.79 M (1Y)
Revenue for trailing 12 months increased 13.32% year over year from 31st December, 2023.
If compared to the last 4 years, the revenue has gone up from $152.00 thousand to $264.79 million, a 174,103.95% change.
Market Capitalization
TG Therapeutics, Inc. has a market capitalization of $5.46B, which places TGTX in the mid-cap category.
Fundamental Analysis
EPS: $0.03 (Q3), $0.09 (1Y)
EPS decreased 40.00% since last quarter, and decreased 106.16% since last year.
Net Income: $3.88 M (Q3), $12.67 M (1Y)
Net Income decreased 43.60% since last quarter, and decreased 106.39% since last year.
Free Cash Flow: $-12.23 M (Q3), $-31.41 M (1Y)
Free Cash Flow decreased 320.90% since last quarter, and decreased 82.17% since last year.
Net Profit Margin: 4.63% (Q3), 4.79% (1Y)
Net Profit Margin decreased 50.60% since last quarter, and decreased 105.64% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for TGTX stock. These indicators help you understand TG Therapeutics, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for TGTX stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $28.94 |
| SMA50 | $25.61 |
| SMA200 | $19.72 |
| RSI | 74.99 |
| Beta | 2.19 |
SMA20 < Current Price
This signals TGTX stock is in short-term bullish momentum.
SMA50 < Current Price
This signals TGTX stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals TGTX stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for TGTX stock is Bullish. Out of all indicators, 5 indicates bullish signals, 2 signals bearish trends and 2 gives neutral trends. The TGTX stock forecast was last updated on 25 November, 2024.
TG Therapeutics, Inc. (TGTX) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $35.07 by the end of 2024, and can reach around $23.61 to $13.40 in 2025. And, the long-term forecast suggests that the stock may further drop to $37.21 - $25.08 in 2027, and $36.87 - $29.93 by 2030. So, the TGTX stock shows a strong upward trend in the next several years.
Short-term TGTX Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2024-12 | $35.07 | 0.0% |
In 2024, the TGTX stock price is expected to fluctuate between $35.07 and $35.07. According to the monthly forecast, the stock could rise to $35.07 by December 2024. If compared to the TGTX's current price, the stock could gain 0.0% by the end of this year.
Long-term TGTX Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2025 | $23.61 | $24.23 | $13.40 | -61.79% |
| 2026 | $47.73 | $14.60 | $30.97 | -11.69% |
| 2027 | $37.21 | $29.91 | $25.08 | -28.49% |
| 2028 | $40.59 | $19.67 | $22.61 | -35.53% |
| 2029 | $36.13 | $25.26 | $18.68 | -46.74% |
| 2030 | $36.87 | $23.57 | $29.93 | -14.66% |
| 2031 | $40.59 | $20.98 | $14.15 | -59.65% |
| 2032 | $28.62 | $39.96 | $30.78 | -12.23% |
| 2033 | $20.94 | $31.76 | $29.78 | -15.08% |
| 2034 | $26.39 | $33.34 | $8.31 | -76.3% |
| 2035 | $46.47 | $31.58 | $29.06 | -17.14% |
| 2036 | $33.17 | $28.75 | $29.31 | -16.42% |
| 2037 | $46.38 | $35.22 | $18.93 | -46.02% |
| 2038 | $26.47 | $27.06 | $21.17 | -39.64% |
| 2039 | $37.37 | $37.47 | $18.71 | -46.65% |
| 2040 | $41.77 | $60.70 | $37.15 | 5.93% |
| 2041 | $22.47 | $50.51 | $43.06 | 22.78% |
| 2042 | $42.26 | $41.37 | $37.10 | 5.79% |
| 2043 | $57.87 | $38.64 | $36.90 | 5.22% |
| 2044 | $48.17 | $41.40 | $12.04 | -65.67% |
| 2045 | $44.81 | $36.02 | $37.36 | 6.53% |
| 2046 | $38.48 | $34.25 | $10.15 | -71.06% |
| 2047 | $61.80 | $43.99 | $18.99 | -45.85% |
| 2048 | $44.00 | $37.79 | $29.87 | -14.83% |
| 2049 | $49.18 | $40.13 | $28.45 | -18.88% |
| 2050 | $37.59 | $28.01 | $20.32 | -42.06% |
TG Therapeutics, Inc. (TGTX) Stock Price Prediction & Forecast 2024 - 2025
At the start of 2024, the TGTX stock was at $16.24. Today, it is trading at $35.07, which is 115.95% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $35.07 by December 2024 with a 0.00% change.
In early 2025, the TGTX price is expected to descend from $35.07 to $23.61, a change of -32.67% from the current price. By mid-2025, the stock may move up by 2.63% on $24.23 and end the year at $13.40, which is -61.79% compared to today's price.
TG Therapeutics, Inc. (TGTX) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the TGTX stock. During this period, the TGTX's price is forecasted to shift from $47.73 to $29.93, which is -37.29% loss.
In 2026, the stock would possibly open at $47.73, descends to $14.60 by mid-year, and wraps up at $30.97, reflecting a decrease from today's price. Further moving to 2030, the stock can kick off the year at $36.87, drop to $23.57 by mid-year, and finish at $29.93, which is -14.64% change from current price.
TG Therapeutics, Inc. (TGTX) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $40.59 to $37.15, which is down -59.65%
In 2031, we can expect TGTX to fluctuate between $14.15 and $40.59, a shift indicating a -59.65% loss by year-end compared to current price. And Until 2040, TGTX can likely vary from $37.15 to $41.77. By the end of 2040, the stock could record a 5.93% rise from today's stock price.
TG Therapeutics, Inc. (TGTX) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the TGTX stock can see an a downturn from $22.47 to $20.32 in this period. In 2041, the stock can experience a high of $50.51 by mid-year, closing the year at $43.06. This results in a 44.02% increase from today.
Moving towards the end of 2050, TGTX is projected to open the year at $37.59. The stock may dip to $28.01 during mid-year and finish the year at $20.32. Compared to the stock's current price, this translates to an overall loss of -42.07% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
TGTX : Buy, Sell Or Hold?
Analyst Ratings
Based on 8 analysts, 1 rated as a strong buy, 6 recommended a buy, 1 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 6 analysts, 1 analysts gave a strong buy rating, 5 a buy rating, 0 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for TGTX stock is Buy.
Expert Analysis
According to TGTX short-term and long-term forecast, TG Therapeutics, Inc. shares are projected to go down by 42.06%, and reach a value of $20.32 per share by 2050.
As per technical analysis, indicators show a Bullish sentiment, while Fear & Greed Index stands at 85.71428571428571, which signals Greed. Also, TGTX has recorded 16/30 green days, which reflects a 72.72727272727273% positivity rate with a price volatility of 0.05%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that TGTX stock is undervalued. So, Based on TGTX prediction and analysis, it may be the best time to buy TGTX stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "TGTX” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.